How protected classes in Medicare Part D influence U.S. drug sales, utilization, and price-Reference-Cited by-同舟云学术

How protected classes in Medicare Part D influence U.S. drug sales, utilization, and price

Published:2020-05 Issue:5 Volume:29 Page:608-623
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Economics

Author:

Yarbrough Courtney R.¹^ORCID

Affiliation:

1. Department of Health Policy and Management, Rollins School of Public HealthEmory University Atlanta Georgia

Publisher

Wiley

Subject

Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hec.4006

Reference42 articles.

1. A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets

2. Pricing and Reimbursement in U.S. Pharmaceutical Markets

3. Besanko D. Dranove D. &Garthwaite C.(2016).Insurance and the high prices of pharmaceuticals.National Bureau of Economic Research Working Paper Series No. 22353.https://doi.org/10.3386/w22353

4. Centers for Medicare & Medicaid Services. (2010).Medicare prescription drug benefit manual. Retrieved fromhttps://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/partdmanuals.html

5. Centers for Medicare & Medicaid Services. (2013).Protected classes review panel. Retrieved fromhttps://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet/76/4/Protected%20class%20review%20panel.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why Does the Inflation Reduction Act Exclude Expensive Cancer Treatments in Price Negotiations?;JCO Oncology Practice;2023-12-07

2. Revisiting the effect of recreational marijuana on traffic fatalities;International Journal of Drug Policy;2023-05

3. Drug Pricing;Physician Crisis;2023

4. Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs;Health Economics;2022-11-18

5. Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulators;Journal of Medical Economics;2022-09-28